SI3190116T1 - Pirazolotiazolna spojina in zdravilo, ki le-to vsebuje - Google Patents

Pirazolotiazolna spojina in zdravilo, ki le-to vsebuje

Info

Publication number: SI3190116T1
Authority: SI; Slovenia
Prior art keywords: medicine; same; pyrazolothiazole compound; pyrazolothiazole; compound
Prior art date: 2014-09-02

Application number

SI201531340T

Other languages

English (en)

Inventor

Yoshinobu Shiba

Satoshi Akiyama

Original Assignee

Nippon Shinyaku Co., Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-09-02

Filing date

2015-09-02

Publication date

2020-10-30

2015-09-02 Application filed by Nippon Shinyaku Co., Ltd. filed Critical Nippon Shinyaku Co., Ltd.

2020-10-30 Publication of SI3190116T1 publication Critical patent/SI3190116T1/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Transplantation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

SI201531340T 2014-09-02 2015-09-02 Pirazolotiazolna spojina in zdravilo, ki le-to vsebuje SI3190116T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2014177969		2014-09-02
PCT/JP2015/074935 WO2016035814A1 (ja)	2014-09-02	2015-09-02	ピラゾロチアゾール化合物および医薬
EP15838466.9A EP3190116B1 (en)	2014-09-02	2015-09-02	Pyrazolothiazole compound and medicine comprising same

Publications (1)

Publication Number	Publication Date
SI3190116T1 true SI3190116T1 (sl)	2020-10-30

Family

ID=55439874

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI201531340T SI3190116T1 (sl)	2014-09-02	2015-09-02	Pirazolotiazolna spojina in zdravilo, ki le-to vsebuje

Country Status (34)

Country	Link
US (2)	US9937176B2 (sl)
EP (1)	EP3190116B1 (sl)
JP (1)	JP6558372B2 (sl)
KR (1)	KR102294330B1 (sl)
CN (1)	CN107108653B (sl)
AU (1)	AU2015312886B2 (sl)
BR (1)	BR112017003800B1 (sl)
CA (1)	CA2959721C (sl)
CL (1)	CL2017000478A1 (sl)
CO (1)	CO2017002982A2 (sl)
CY (1)	CY1123320T1 (sl)
DK (1)	DK3190116T3 (sl)
ES (1)	ES2827243T3 (sl)
HR (1)	HRP20201382T1 (sl)
HU (1)	HUE050565T2 (sl)
IL (1)	IL250729B (sl)
LT (1)	LT3190116T (sl)
MA (1)	MA40605B1 (sl)
MX (1)	MX377926B (sl)
MY (1)	MY181814A (sl)
NZ (1)	NZ729494A (sl)
PE (1)	PE20170668A1 (sl)
PH (1)	PH12017500383B1 (sl)
PL (1)	PL3190116T3 (sl)
PT (1)	PT3190116T (sl)
RS (1)	RS60798B1 (sl)
RU (1)	RU2688660C2 (sl)
SG (2)	SG11201701447UA (sl)
SI (1)	SI3190116T1 (sl)
SM (1)	SMT202000503T1 (sl)
TW (1)	TWI679205B (sl)
UA (1)	UA121869C2 (sl)
WO (1)	WO2016035814A1 (sl)
ZA (1)	ZA201701492B (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI679205B (zh) *	2014-09-02	2019-12-11	日商日本新藥股份有限公司	吡唑并噻唑化合物及醫藥
TWI712604B (zh)	2016-03-01	2020-12-11	日商日本新藥股份有限公司	具jak抑制作用之化合物之結晶
CN110709346B (zh)	2017-06-09	2020-12-22	三菱电机株式会社	乘客输送机
EP4081199A4 (en) *	2019-12-23	2024-01-17	SRI International	LIPOXYGENASE INHIBITORS
JP7742516B1 (ja) *	2025-07-31	2025-09-19	日本新薬株式会社	好酸球性多発血管炎性肉芽腫症の処置剤

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3600390A1 (de)	1986-01-09	1987-07-16	Hoechst Ag	Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel
US5017212A (en) *	1986-03-20	1991-05-21	Takeda Chemical Industries, Ltd.	Sulfonylurea compounds and herbicidal use
US5082847A (en)	1990-07-18	1992-01-21	Syntex (U.S.A.) Inc.	Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility
GB0216383D0 (en)	2002-07-13	2002-08-21	Astrazeneca Ab	Compounds
GB2432834A (en)	2004-01-12	2007-06-06	Cytopia Res Pty Ltd	Selective Kinase Inhibitors
BRPI0510340A (pt)	2004-04-28	2007-10-30	Pfizer	derivados de 3-heterociclil-4-feniltriazol como inibidores do receptor via da vasopressina
NZ567133A (en) *	2005-09-30	2011-07-29	Vertex Pharma	Deazapurines useful as inhibitors of janus kinases
MY167260A (en) *	2005-11-01	2018-08-14	Targegen Inc	Bi-aryl meta-pyrimidine inhibitors of kinases
NZ601687A (en)	2006-01-17	2014-03-28	Vertex Pharma	Azaindoles useful as inhibitors of janus kinases
MX2010010012A (es)	2008-03-11	2010-10-20	Incyte Corp	Derivados de azetidina y ciclobutano como inhibidores de jak.
ES2396126T3 (es) *	2008-04-15	2013-02-19	Eisai R&D Management Co., Ltd.	Compuesto de 3-fenilpirazol[5,1-b]tiazol
JO3041B1 (ar)	2008-07-25	2016-09-05	Galapagos Nv	مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية
EP2373664B1 (en) *	2008-12-19	2013-06-12	Nerviano Medical Sciences S.r.l.	Bicyclic pyrazoles as protein kinase inhibitors
TWI462920B (zh)	2009-06-26	2014-12-01	葛萊伯格有限公司	用於治療退化性及發炎疾病之新穎化合物
JP5739446B2 (ja)	2009-12-18	2015-06-24	ファイザー・インク	ピロロ［２，３−ｄ］ピリミジン化合物
TW201124078A (en)	2009-12-22	2011-07-16	Du Pont	Fungicidal 2-(bicyclic aryloxy) carboxamides
EP2338888A1 (en)	2009-12-24	2011-06-29	Almirall, S.A.	Imidazopyridine derivatives as JAK inhibitors
JP2011136925A (ja)	2009-12-28	2011-07-14	Dainippon Sumitomo Pharma Co Ltd	含窒素二環性化合物
KR20140015162A (ko)	2010-01-12	2014-02-06	에프. 호프만-라 로슈 아게	트라이사이클릭 헤테로사이클릭 화합물, 조성물 및 이의 사용 방법
UY33213A (es)	2010-02-18	2011-09-30	Almirall Sa	Derivados de pirazol como inhibidores de jak
JP2013532184A (ja)	2010-07-12	2013-08-15	ファイザー・リミテッド	電位開口型ナトリウムチャネル阻害剤として有用なｎ−スルホニルベンズアミド誘導体
WO2012022045A1 (en)	2010-08-20	2012-02-23	Hutchison Medipharma Limited	Pyrrolopyrimidine compounds and uses thereof
EP2616443A1 (en)	2010-09-14	2013-07-24	Exelixis, Inc.	Phtalazine derivatives as jak1 inhibitors
WO2012054364A2 (en)	2010-10-22	2012-04-26	Merck Sharp & Dohme Corp.	Bicyclic diamines as janus kinase inhibitors
WO2012085176A1 (en)	2010-12-23	2012-06-28	F. Hoffmann-La Roche Ag	Tricyclic pyrazinone compounds, compositions and methods of use thereof as janus kinase inhibitors
WO2013025628A1 (en) *	2011-08-15	2013-02-21	Ligand Pharmaceuticals Incorporated	Janus kinase inhibitor compounds and methods
TWI679205B (zh) *	2014-09-02	2019-12-11	日商日本新藥股份有限公司	吡唑并噻唑化合物及醫藥

2015
- 2015-09-01 TW TW104128865A patent/TWI679205B/zh active
- 2015-09-02 MA MA40605A patent/MA40605B1/fr unknown
- 2015-09-02 AU AU2015312886A patent/AU2015312886B2/en active Active
- 2015-09-02 PL PL15838466T patent/PL3190116T3/pl unknown
- 2015-09-02 LT LTEP15838466.9T patent/LT3190116T/lt unknown
- 2015-09-02 MX MX2017002488A patent/MX377926B/es unknown
- 2015-09-02 KR KR1020177008967A patent/KR102294330B1/ko active Active
- 2015-09-02 CA CA2959721A patent/CA2959721C/en active Active
- 2015-09-02 HU HUE15838466A patent/HUE050565T2/hu unknown
- 2015-09-02 SM SM20200503T patent/SMT202000503T1/it unknown
- 2015-09-02 SG SG11201701447UA patent/SG11201701447UA/en unknown
- 2015-09-02 RU RU2017110535A patent/RU2688660C2/ru active
- 2015-09-02 HR HRP20201382TT patent/HRP20201382T1/hr unknown
- 2015-09-02 BR BR112017003800-5A patent/BR112017003800B1/pt active IP Right Grant
- 2015-09-02 ES ES15838466T patent/ES2827243T3/es active Active
- 2015-09-02 JP JP2016546669A patent/JP6558372B2/ja active Active
- 2015-09-02 PT PT158384669T patent/PT3190116T/pt unknown
- 2015-09-02 SI SI201531340T patent/SI3190116T1/sl unknown
- 2015-09-02 CN CN201580058944.7A patent/CN107108653B/zh active Active
- 2015-09-02 DK DK15838466.9T patent/DK3190116T3/da active
- 2015-09-02 MY MYPI2017700677A patent/MY181814A/en unknown
- 2015-09-02 NZ NZ729494A patent/NZ729494A/en unknown
- 2015-09-02 PE PE2017000370A patent/PE20170668A1/es unknown
- 2015-09-02 EP EP15838466.9A patent/EP3190116B1/en active Active
- 2015-09-02 WO PCT/JP2015/074935 patent/WO2016035814A1/ja not_active Ceased
- 2015-09-02 RS RS20201081A patent/RS60798B1/sr unknown
- 2015-09-02 UA UAA201702990A patent/UA121869C2/uk unknown
- 2015-09-02 SG SG10201901676UA patent/SG10201901676UA/en unknown
- 2015-09-02 US US15/505,767 patent/US9937176B2/en active Active
2017
- 2017-02-23 IL IL250729A patent/IL250729B/en active IP Right Grant
- 2017-02-28 ZA ZA2017/01492A patent/ZA201701492B/en unknown
- 2017-02-28 CL CL2017000478A patent/CL2017000478A1/es unknown
- 2017-03-01 PH PH12017500383A patent/PH12017500383B1/en unknown
- 2017-03-27 CO CONC2017/0002982A patent/CO2017002982A2/es unknown
- 2017-12-04 US US15/830,181 patent/US9999622B2/en active Active
2020
- 2020-09-04 CY CY20201100832T patent/CY1123320T1/el unknown

Also Published As

Publication number	Publication date
PH12017500383A1 (en)	2017-07-17
IL250729A0 (en)	2017-04-30
LT3190116T (lt)	2020-11-10
AU2015312886A1 (en)	2017-03-16
US20170252341A1 (en)	2017-09-07
MX377926B (es)	2025-03-10
PL3190116T3 (pl)	2020-11-30
MX2017002488A (es)	2017-05-23
TW201613942A (en)	2016-04-16
ES2827243T3 (es)	2021-05-20
MY181814A (en)	2021-01-08
DK3190116T3 (da)	2020-09-07
US20180092919A1 (en)	2018-04-05
WO2016035814A1 (ja)	2016-03-10
SG11201701447UA (en)	2017-03-30
MA40605A (fr)	2017-07-12
RS60798B1 (sr)	2020-10-30
HRP20201382T1 (hr)	2020-11-27
HUE050565T2 (hu)	2020-12-28
MA40605B1 (fr)	2020-10-28
CA2959721C (en)	2022-10-25
BR112017003800A2 (pt)	2017-11-28
CL2017000478A1 (es)	2017-11-10
CN107108653A (zh)	2017-08-29
NZ729494A (en)	2022-04-29
KR102294330B1 (ko)	2021-08-25
EP3190116B1 (en)	2020-08-05
CA2959721A1 (en)	2016-03-10
US9937176B2 (en)	2018-04-10
CY1123320T1 (el)	2021-12-31
KR20170044202A (ko)	2017-04-24
EP3190116A1 (en)	2017-07-12
RU2688660C2 (ru)	2019-05-22
ZA201701492B (en)	2022-05-25
RU2017110535A3 (sl)	2018-10-31
SMT202000503T1 (it)	2020-11-10
UA121869C2 (uk)	2020-08-10
JPWO2016035814A1 (ja)	2017-06-22
TWI679205B (zh)	2019-12-11
RU2017110535A (ru)	2018-10-04
US9999622B2 (en)	2018-06-19
CN107108653B (zh)	2019-04-09
PE20170668A1 (es)	2017-06-06
CO2017002982A2 (es)	2017-07-11
PH12017500383B1 (en)	2019-11-20
JP6558372B2 (ja)	2019-08-14
PT3190116T (pt)	2020-09-04
BR112017003800B1 (pt)	2022-09-13
EP3190116A4 (en)	2018-04-04
IL250729B (en)	2019-09-26
SG10201901676UA (en)	2019-03-28
AU2015312886B2 (en)	2020-02-06

Publication	Publication Date	Title
IL252532A0 (en)	2017-07-31	Polycyclic carbamoylpyridone compounds and their pharmaceutical use
IL252216A0 (en)	2017-07-31	Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines
IL254552A0 (en)	2017-11-30	Polycyclic carbamoylpyridone compounds and their pharmaceutical uses
IL283335B (en)	2022-04-01	Dihydropyrimidine-2-one compounds and their medical use
ZA201801134B (en)	2019-07-31	Hydroxytriazine compound and medical use thereof
IL250729B (en)	2019-09-26	A pyrazolothiazole compound and a drug containing it
PL3094338T3 (pl)	2022-08-08	Oznaczenie i lek
GB201601991D0 (en)	2016-03-23	Medicine
PL3229772T3 (pl)	2020-11-02	6-arylo-9-glikozylopuryny i ich zastosowanie
GB201514770D0 (en)	2015-09-30	Compounds and their use
GB201413411D0 (en)	2014-09-10	Novel compounds and their use
GB201404301D0 (en)	2014-04-23	Compounds and combinations
GB201404728D0 (en)	2014-04-30	Disc-over incorporating disc-heads and disc-earning